Magnesium Intake Associated WIth Lower Risk of Pancreatic Cancer
Pancreatic cancer is one of the most deadly cancers for both men and women, with a very low five-year survival rate. A recent study suggests that magnesium intake may be associated with incidence of pancreatic cancer.
Participants in the study included more than 66,000 men and women between the ages of 50 and 76 who took part in the VITamins and Lifestyle study. The researchers examined the association between magnesium and pancreatic cancer as well as whether age, gender, body mass index, non-steroidal anti-inflammatory drugs, and magnesium supplementation had any effect.
During an average 6.8 years of follow up, 151 of the participants developed pancreatic cancer. After examining the data, the researchers found that every 100-milligram-per-day decrease in magnesium intake was associated with a 24% increase in the occurrence of pancreatic cancer.
Age, gender, body mass index, and non-steroidal anti-inflammatory drug use did not appear to effect the association between magnesium and pancreatic cancer incidence. However, the reduced risk was limited to those taking a supplement of either magnesium on its own or in a multivitamin.
Researchers from Indiana University conducted the study. It was published on December 1, 2015, in the British Journal of Cancer.
Magnesium is necessary for more than 300 biochemical reactions in the body. Previous studies have found that higher intakes of magnesium may reduce the risk of diabetes, stroke, high blood pressure and osteoporosis.
Eating more magnesium rich foods such as green leafy vegetables, meats, starches, grains, nuts and milk is one way to increase your magnesium intake. Taking a supplement is also a good option.